ADME Toxicology Testing Market Report 2026

ADME Toxicology Testing Market Overview

• ADME Toxicology Testing market size has reached to $11.5 billion in 2025 • Expected to grow to $20.25 billion in 2030 at a compound annual growth rate (CAGR) of 12.1% • Growth Driver: Surge In Demand For Novel Drugs Propels Growth In The ADME Toxicology Testing Market • Market Trend: Evotec's Cyprotex E-Store Revolutionizes ADME-Tox Service Access • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under ADME Toxicology Testing Market?

ADME toxicology testing is a set of studies conducted to assess the potential toxicity of a substance or drug candidate based on its absorption, distribution, metabolism, and excretion (ADME) properties. These tests are used in drug development to ensure the well-being of individuals exposed to substances. The main products of ADME toxicology testing are instruments, software solutions, assay systems, reagents, and others. Instruments refer to devices or tools that are designed and used for a specific purpose, often in scientific, medical, or technical contexts. It is used in ADME toxicity testing for measuring and analyzing the readings. The methods used are cellular assay, biochemical assay, in silica, and ex-vivo, by accompanying technologies such as, sing cell culture, high throughput, molecular imaging, omics technology, and other technologies. It is applied for systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and others by cosmetics and household products, pharmaceutical industry, animal industry, food industry, and others.

What Is The ADME Toxicology Testing Market Growth Forecast?

The adme toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $20.25 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to development of integrated adme platforms, rising application of omics and molecular imaging technologies, increasing investment in predictive toxicology software, expansion of adme testing in cosmetics and food industries, adoption of ai-driven risk assessment solutions. Major trends in the forecast period include growing adoption of high-throughput screening instruments, increasing use of cell-based and in vitro assays, rising demand for omics-based toxicology technologies, expansion of adme testing in pharmaceutical development, integration of simulation and modeling software in risk assessment.

Global ADME Toxicology Testing Market Segmentation

1) By Product Type: Instruments, Software Solutions, Assays Systems, Reagents, Other Product Types 2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-Vivo 3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies 4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications 5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users Subsegments: 1) By Instruments: High-Throughput Screening Instruments, LC-MS Or MS (Liquid Chromatography-Mass Spectrometry), HPLC (High-Performance Liquid Chromatography), Automated Workstations 2) By Software Solutions: Data Management Software, Simulation And Modeling Software, Risk Assessment Software 3) By Assay Systems: Cell-Based Assays, In Vitro Assays, Bioanalytical Assays 4) By Reagents: Biochemicals, Buffer Solutions, Culture Media 5) By Other Products: Kits And Consumables, Analytical Standards

What Are The Drivers Of The ADME Toxicology Testing Market?

The rising demand for novel drugs is expected to propel the growth of the ADME toxicology testing market going forward. Novel drugs are pharmaceutical substances that have not been previously approved or marketed for therapeutic use. ADME toxicity testing is a major step in drug development to ensure that the novel drug is safe and doesn’t produce any harmful toxins in the body. For instance, in January 2024, according to the New Drug Therapy Approvals 2023 report published by the Center for Drug Evaluation and Research (CDER), a US-based branch of the U.S. Food and Drug Administration (FDA), the CDER approved 55 novel drugs in 2023, with 20 (36%) identified as first-in-class, compared to 37 novel drug approvals in 2022. Therefore, the rising demand for novel drugs is driving the growth of the ADME toxicology testing industry. The growing pharmaceutical industry is expected to propel the growth of the ADME toxicology testing market going forward. The pharmaceutical industry is a sector that involves the discovery, development, and production of drugs and medicines by both governmental and private entities. The pharmaceutical industry utilizes ADME toxicology testing to assess the absorption, distribution, metabolism, and excretion (ADME) properties of drug candidates and evaluate their potential toxicity. This testing is crucial for predicting how a drug will behave within the human body, including its absorption rates, distribution to target tissues, metabolism, and elimination. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association that represents the pharmaceutical industry in Europe, the total pharmaceutical production in Europe accounted for €390,000 million ($422,803 million) in 2023, up from €363,300 million ($393,857 million) in 2022. Therefore, the growing pharmaceutical industry is driving the growth of the ADME toxicology testing industry.

Key Players In The Global ADME Toxicology Testing Market

Major companies operating in the adme toxicology testing market are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

Global ADME Toxicology Testing Market Trends and Insights

Major companies operating in the ADME toxicology testing market are introducing the integration of advanced technologies such as Cyprotex e-Store for online ordering of ADME-Tox services. ADME-Tox services aim to save development costs and time, reduce the likelihood of failure at a later stage, and enable the selection of the best candidate for clinical development. For instance, in October 2023, Evotec SE, a Germany-based biotechnology company, launched the Cyprotex e-Store, an e-commerce platform that provides simplified online access to the company's comprehensive range of ADME-Tox services. The e-Store streamlines and accelerates the buying process, allowing registered users to evaluate and order Cyprotex' offerings around the clock, seven days a week. It offers instant access to prices and detailed protocols online, and users can easily place orders, track them, and reorder when needed. This efficient platform reduces the lead time for services, enabling users to receive their data quicker.

Regional Outlook

North America was the largest region in the ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the ADME Toxicology Testing Market?

The ADME toxicology testing market consists of revenues earned by entities by providing services such as drug discovery research, measuring gene expression, and preclinical efficacy testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The ADME toxicology testing market also includes sales of ADMET predictors, and UV spectrophotometers, which are used in providing ADME toxicology testing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the ADME Toxicology Testing Market Report 2026?

The adme toxicology testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the adme toxicology testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.